Incidence of Bleeding Complications in Pediatric Patients with Type 1 von Willebrand Disease Undergoing Adenotonsillar Procedures

被引:36
|
作者
Witmer, Char M. [1 ]
Elden, Lisa [2 ]
Butler, Regina B. [1 ]
Manno, Catherine S. [3 ]
Raffini, Leslie J. [1 ]
机构
[1] Univ Penn, Childrens Hosp Philadelphia, Dept Pediat, Div Hematol,Sch Med, Philadelphia, PA 19104 USA
[2] Univ Penn, Childrens Hosp Philadelphia, Dept Otolaryngol, Div Surg,Sch Med, Philadelphia, PA 19104 USA
[3] NYU, Sch Med, Dept Pediat, Div Hematol Oncol, New York, NY USA
来源
JOURNAL OF PEDIATRICS | 2009年 / 155卷 / 01期
关键词
TONSILLECTOMY; CHILDREN; ADENOIDECTOMY; MANAGEMENT; HEMORRHAGE; SURGERY; AUDIT; PREVALENCE;
D O I
10.1016/j.jpeds.2009.01.051
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objective To review the incidence of postoperative bleeding in children with type 1 von Willebrand disease (VWD) who were treated with a single institution protocol. Study design We performed a retrospective study to determine the postoperative hemorrhage rate in pediatric patients with type 1 VWD who were treated via the Children's Hospital of Philadelphia institutional protocol. This protocol utilizes intravenous desmopressin (DDAVP), oral aminocaproic acid, and overnight observation. Results Between the years of 2000 to 2006, 41 children with type 1 VWD underwent an adenotonsillar procedure and were treated with this protocol. Seven patients (17%) experienced delayed (> 24 hours after surgery) postoperative hemorrhage requiring intervention. Five of the 7 patients required cautery to control the bleeding, and the remaining 2 patients responded to DDAVP and aminocaproic acid alone. Older age and lower VW antigen levels were associated with postoperative hemorrhage (P = .05). Conclusions Despite therapeutic intervention to decrease the risk of postoperative hemorrhage, the incidence of hemorrhage was higher in pretreated patients with type 1 VWD than in children without bleeding disorders. Further prospective studies are necessary to determine the optimal treatment to reduce bleeding complications in these patients. (J Pediatr 2009;155:68-72).
引用
收藏
页码:68 / 72
页数:5
相关论文
共 50 条
  • [41] Incidence and Trends in Bleeding and Vascular Complications Among Patients Undergoing Large-Bore Access Procedures
    Garg, Aakash
    Majmundar, Monil
    Rout, Amit
    Gordon, Paul
    Tayal, Rajiv
    Dangas, George
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 80 (12) : B245 - B245
  • [42] Perioperative bleeding and thrombotic risks in patients with Von Willebrand disease
    Nathaniel R. Smilowitz
    Navdeep Gupta
    Yu Guo
    Sripal Bangalore
    Jeffrey S. Berger
    Journal of Thrombosis and Thrombolysis, 2017, 44 : 67 - 70
  • [43] Haemostatic management of intraoral bleeding in patients with von Willebrand disease
    Morimoto, Y
    Yoshioka, A
    Sugimoto, M
    Imai, Y
    Kirita, T
    ORAL DISEASES, 2005, 11 (04) : 243 - 248
  • [44] Von Willebrand factor propeptide makes it easy to identify the shorter Von Willebrand factor survival in patients with type 1 and type Vicenza von Willebrand disease
    Sztukowska, M.
    Gallinaro, L.
    Cattini, M. G.
    Pontara, E.
    Sartorello, F.
    Daidone, V.
    Padrini, R.
    Pagnan, A.
    Casonato, A.
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 143 (01) : 107 - 114
  • [45] Quantitation of bleeding symptoms in children with von Willebrand disease: use of a standardized pediatric bleeding questionnaire
    Biss, T. T.
    Blanchette, V. S.
    Clark, D. S.
    Bowman, M.
    Wakefield, C. D.
    Silva, M.
    Lillicrap, D.
    James, P. D.
    Rand, M. L.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2010, 8 (05) : 950 - 956
  • [46] Practical aspects of DDAVP use in patients with von Willebrand Disease undergoing invasive procedures: a European survey
    Windyga, J.
    Dolan, G.
    Altisent, C.
    Katsarou, O.
    Lopez Fernandez, M. -F.
    Zulfikar, B.
    HAEMOPHILIA, 2016, 22 (01) : 110 - 120
  • [47] A Novel Microfluidic Assay to Determine Von Willebrand Factor Levels and Bleeding Phenotypes in Patients with Von Willebrand Disease and Mucocutaneous Bleeding
    Ng, Christopher J.
    Lehman, Marcus
    Manco-Johnson, Marilyn
    Neeves, Keith B.
    Di Paola, Jorge A.
    BLOOD, 2015, 126 (23)
  • [48] Increased O-linked glycosylation of von Willebrand factor in patients with von Willebrand disease type 1
    Van Schooten, CJM
    Van den Berg, HM
    De Groot, PG
    Lenting, PJ
    BRITISH JOURNAL OF HAEMATOLOGY, 2006, 133 : 18 - 19
  • [49] Von Willebrand disease type 1 and pregnancy
    Scholz, U.
    Oppermann, J.
    Siegemund, A.
    Schobess, R.
    HAMOSTASEOLOGIE, 2011, 31 (4A): : S11 - S13
  • [50] Genetics of type 1 von Willebrand disease
    Goodeve, Anne
    CURRENT OPINION IN HEMATOLOGY, 2007, 14 (05) : 444 - 449